Devises / MRVI
MRVI: Maravai LifeSciences Holdings Inc - Class A
2.67
USD
0.04
(1.48%)
Le taux de change de MRVI a changé de -1.48% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 2.63 et à un maximum de 2.75.
Suivez la dynamique Maravai LifeSciences Holdings Inc - Class A. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MRVI Nouvelles
- Investing Maravai LifeSciences stock rating reiterated amid leadership changes
- Investing Maravai LifeSciences appoints Raj Asarpota as new CFO
- Investing Maravai LifeSciences names Bernd Brust as new CEO
- Seeking Alpha Harbor AlphaEdge Small Cap Earners ETF Q1 2025 Commentary (EBIT)
- Investing Maravai ratings downgraded by Moody’s over weakened performance
- Investing TriLink and Quantoom partner to expand global vaccine access
- Investing Maravai LifeSciences Announces Shareholder Meeting Results
- Seeking Alpha Lazard U.S. Small Cap Equity Select Portfolio Q1 2025 Commentary
- Investing Maravai ratings drop to ’B-’ at S&P due to decline in revenue and EBITDA
- Investing CORRECTION “ Maravai LifeSciences Releases 2024 Sustainability Report
- Investing TriLink BioTechnologies ® debuts its first mRNA synthesis kit with CleanCap ® capping technology; Celebrates launch with kit donations to top academic institutions
- Investing TriLink BioTechnologies ® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
- Benzinga These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results - Maravai LifeSciences (NASDAQ:MRVI)
- Seeking Alpha Maravai LifeSciences: Upside Not Likely In 2025, But Company Can Survive (NASDAQ:MRVI)
- Seeking Alpha Columbia Acorn Fund Q4 2024 Commentary (ACRNX)
- Investing ROSEN, A LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI
- The Motley Fool Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript
- Seeking Alpha Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call Transcript
- Seeking Alpha Maravai LifeSciences Holdings, Inc. 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:MRVI)
- The Motley Fool 3 Struggling Stocks Down More Than 50% This Year That Look Cheap But Come With Plenty of Risk
- Investing Maravai shares tumble after earnings delay
Range quotidien
2.63
2.75
Range Annuel
1.66
9.96
- Clôture Précédente
- 2.73
- Ouverture
- 2.71
- Bid
- 2.67
- Ask
- 2.97
- Plus Bas
- 2.63
- Plus Haut
- 2.75
- Volume
- 1.525 K
- Changement quotidien
- -1.48%
- Changement Mensuel
- 11.72%
- Changement à 6 Mois
- -45.29%
- Changement Annuel
- -72.59%
15 juillet, mardi
11:00
ALL
- Act
- Fcst
- Prev
12:30
USD
- Act
- Fcst
- -0.3%
- Prev
- 0.1%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- 0.1%
12:30
USD
- Act
- Fcst
- 2.4%
- Prev
- 2.4%
12:30
USD
- Act
- Fcst
- 2.7%
- Prev
- 2.8%
12:30
USD
- Act
- Fcst
- 321.516
- Prev
- 321.465
12:30
USD
- Act
- Fcst
- 327.606
- Prev
- 326.854
12:30
USD
- Act
- Fcst
- 0.1%
- Prev
- 0.3%
12:30
USD
- Act
- Fcst
- Prev
- 0.2%
12:30
USD
- Act
- Fcst
- Prev
- 0.2%
12:30
USD
- Act
- Fcst
- 320.395
- Prev
- 320.580
12:30
USD
- Act
- Fcst
- Prev
- 327.509
12:30
USD
- Act
- Fcst
- 2.2
- Prev
- -16.0
13:15
USD
- Act
- Fcst
- Prev
15:00
USD
- Act
- Fcst
- 0.2%
- Prev
- 0.2%
16:45
USD